Peripheral gene transfer of glial cell-derived neurotrophic factor ameliorates neuropathic deficits in diabetic rats

Human Gene Therapy

Volumn 20, Issue 7, 2009, Pages 715-727

  Liu, Guei Sheung ^a,b   Shi, Jhih Yin ^c   Lai, Chiou Lian ^d   Hong, Yi Ren ^d   Shin, Shyi Jang ^d   Huang, Hung Tu ^c   Lam, Hing Chung ^b   Wen, Zhi Hong ^c   Hsu, Kuei Sen ^a   Chen, Chih Hao ^b   Howng, Shen Long ^d   Tai, Ming Hong ^b,c  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR RECEPTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR RECEPTOR ALPHA 1; NEUROPEPTIDE; NEUROTROPHIC FACTOR; PROTEIN KINASE B; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEMYELINATION; DIABETIC NEUROPATHY; DRUG EFFICACY; ELECTROPHYSIOLOGY; FEMALE; GENE THERAPY; GENE TRANSFER; GLIA CELL; NERVE CONDUCTION; NERVE FIBER; NONHUMAN; PATHOGENESIS; PERIPHERAL NERVE; PERIPHERAL NERVOUS SYSTEM; PROTEIN EXPRESSION; RAT; SCIATIC NERVE; SIGNAL TRANSDUCTION;

ANIMALS; AXONS; CALCITONIN GENE-RELATED PEPTIDE; DIABETIC NEUROPATHIES; GENE THERAPY; GENE TRANSFER TECHNIQUES; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HYPERGLYCEMIA; INJECTIONS, INTRAMUSCULAR; MYELIN SHEATH; RATS; SCIATIC NERVE; SIGNAL TRANSDUCTION; STREPTOZOCIN; SUBSTANCE P;

RATTUS;

EID: 68949219494     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2009.002     Document Type: Article

References (50)

1. Airaksinen, M.S., and Saarma, M. (2002). The GDNF family: Signalling, biological functions and therapeutic value. Nat. Rev. Neurosci. 3, 383-394.
2. Akkina, S.K., Patterson, C.L., and Wright, D.E. (2001). GDNF rescues nonpeptidergic unmyelinated primary afferents in streptozotocin-treated diabetic mice. Exp. Neurol. 167, 173-182.
3. Anand, P. (2004). Neurotrophic factors and their receptors in human sensory neuropathies. Prog. Brain Res. 146, 477-492.
4. Anitha, M., Gondha, C., Sutliff, R., Parsadanian, A., Mwangi, S., Sitaraman, S.V., and Srinivasan, S. (2006). GDNF rescues hyperglycemia-induced diabetic enteric neuropathy through activation of the PI3K/Akt pathway. J. Clin. Invest. 116, 344-356.
5. Apfel, S.C. (1999). Neurotrophic factors in peripheral neuropathies: Therapeutic implications. Brain Pathol. 9, 393-413.
6. Apfel, S.C. (2002). Nerve growth factor for the treatment of diabetic neuropathy: What went wrong, what went right, and what does the future hold? Int. Rev. Neurobiol. 50, 393-413.
7. Apfel, S.C., Schwartz, S., Adornato, B.T., Freeman, R., Biton, V., Rendell, M., Vinik, A., Giuliani, M., Stevens, J.C., Barbano, R., and Dyck, P.J.; rhNGF Clinical Investigator Group. (2000). Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. JAMA 284, 2215-2221.
8. Bar, K.J., Saldanha, G.J., Kennedy, A.J., Facer, P., Birch, R., Carlstedt, T., and Anand, P. (1998). GDNF and its receptor component Ret in injured human nerves and dorsal root ganglia. Neuroreport 9, 43-47.
9. Berns, K.I., and Giraud, C. (1995). Adenovirus and adeno-associated virus as vectors for gene therapy. Ann. N. Y. Acad. Sci. 772, 95-104.
10. Cameron, N.E., Cotter, M.A., and Low, P.A. (1991). Nerve blood flow in early experimental diabetes in rats: Relation to conduction deficits. Am. J. Physiol. 261, E1-E8.
11. Chattopadhyay, M., Krisky, D., Wolfe, D., Glorioso, J.C., Mata, M., and Fink, D.J. (2005). HSV-mediated gene transfer of vascular endothelial growth factor to dorsal root ganglia prevents diabetic neuropathy. Gene Ther. 12, 1377-1384.
12. Choi-Lundberg, D.L., and Bohn, M.C. (1995). Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in rat. Brain Res. Dev. Brain Res. 85, 80-88.
13. Christianson, J.A., Riekhof, J.T., and Wright, D.E. (2003). Restorative effects of neurotrophin treatment on diabetes-induced cutaneous axon loss in mice. Exp. Neurol. 179, 188-199.
14. Coppey, L.J., Davidson, E.P., Dunlap, J.A., Lund, D.D., and Yorek, M.A. (2000). Slowing of motor nerve conduction velocity in streptozotocin-induced diabetic rats is preceded by impaired vasodilation in arterioles that overlie the sciatic nerve. Int. J. Exp. Diabetes Res. 1, 131-143.
15. Fernyhough, P., Diemel, L.T., Hardy, J., Brewster, W.J., Mohiuddin, L., and Tomlinson, D.R. (1995). Human recombinant nerve growth factor replaces deficient neurotrophic support in the diabetic rat. Eur. J. Neurosci. 7, 1107-1110.
16. Fernyhough, P., Diemel, L.T., and Tomlinson, D.R. (1998). Target tissue production and axonal transport of neurotrophin-3 are reduced in streptozotocin-diabetic rats. Diabetologia 41, 300-306.
17. Fox, A., Eastwood, C., Gentry, C., Manning, D., and Urban, L. (1999). Critical evaluation of the streptozotocin model of painful diabetic neuropathy in the rat. Pain 81, 307-316.
18. Gill, S.S., Patel, N.K., Hotton, G.R., O'Sullivan, K., McCarter, R., Bunnage, M., Brooks, D.J., Svendsen, C.N., and Heywood, P. (2003). Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat. Med. 9, 589-595.
19. Goss, J.R., Goins, W.F., Lacomis, D., Mata, M., Glorioso, J.C., and Fink, D.J. (2002). Herpes simplex-mediated gene transfer of nerve growth factor protects against peripheral neuropathy in streptozotocin-induced diabetes in the mouse. Diabetes 51, 2227-2232.
20. Hammarberg, H., Piehl, F., Cullheim, S., Fjell, J., Hokfelt, T., and Fried, K. (1996). GDNF mRNA in Schwann cells and DRG satellite cells after chronic sciatic nerve injury. Neuroreport 7, 857-860.
21. Hoke, A., Cheng, C., and Zochodne, D.W. (2000). Expression of glial cell line-derived neurotrophic factor family of growth factors in peripheral nerve injury in rats. Neuroreport 11, 1651-1654.
22. Hoke, A., Ho, T., Crawford, T.O., Lebel, C., Hilt, D., and Griffin, J.W. (2003). Glial cell line-derived neurotrophic factor alters axon Schwann cell units and promotes myelination in unmyelinated nerve fibers. J. Neurosci. 23, 561-567.
23. Hsieh, M.C., Wu, C.H., Chen, C.L., Chen, H.C., Chang, C.C., and Shin, S.J. (2003). High blood glucose and osmolality, but not high urinary glucose and osmolality, affect neuronal nitric oxide synthase expression in diabetic rat kidney. J. Lab. Clin. Med. 141, 200-209.
24. Iwase, T., Jung, C.G., Bae, H., Zhang, M., and Soliven, B. (2005). Glial cell line-derived neurotrophic factor-induced signaling in Schwann cells. J. Neurochem. 94, 1488-1499.
25. Kato, N., Nemoto, K., Nakanishi, K., Morishita, R., Kaneda, Y., Uenoyama, M., Ikeda, T., and Fujikawa, K. (2005). Nonviral gene transfer of human hepatocyte growth factor improves streptozotocin-induced diabetic neuropathy in rats. Diabetes 54, 846-854.
26. Lai, C.L., Tai, C.T., Liu, C.K., Lin, R.T., and Howng, S.L. (1997). A longitudinal study of central and peripheral nerve conduction in hypothyroid rats. J. Neurol. Sci. 148, 139-145.
27. Lin, L.F., Doherty, D.H., Lile, J.D., Bektesh, S., and Collins, F. (1993). GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260, 1130-1132.
28. Liu, G.S., Liu, L.F., Lin, C.J., Tseng, J.C., Chuang, M.J., Lam, H.C., Lee, J.K., Yang, L.C., Chan, J.H., Howng, S.L., and Tai, M.H. (2006). Gene transfer of pro-opiomelanocortin prohormone suppressed the growth and metastasis of melanoma: Involvement of α-melanocyte-stimulating hormone-mediated inhibition of the nuclear factor κB/cyclooxygenase-2 pathway. Mol. Pharmacol. 69, 440-451.
29. Malcangio, M., Ramer, M.S., Boucher, T.J., and McMahon, S.B. (2000). Intrathecally injected neurotrophins and the release of substance P from the rat isolated spinal cord. Eur. J. Neurosci. 12, 139-144.
30. Manabe, Y., Nagano, I., Gazi, M.S., Murakami, T., Shiote, M., Shoji, M., Kitagawa, H., and Abe, K. (2003). Glial cell line-derived neurotrophic factor protein prevents motor neuron loss of transgenic model mice for amyotrophic lateral sclerosis. Neurol. Res. 25, 195-200.
31. Mazzer, P.Y., Barbieri, C.H., Mazzer, N., and Fazan, V.P. (2008). Morphologic and morphometric evaluation of experimental acute crush injuries of the sciatic nerve of rats. J. Neurosci. Methods 173, 249-258.
32. Mwangi, S., Anitha, M., Mallikarjun, C., Ding, X., Hara, M., Parsadanian, A., Larsen, C.P., Thule, P., Sitaraman, S.V., Anania, F., and Srinivasan, S. (2008). Glial cell line-derived neurotrophic factor increases beta-cell mass and improves glucose tolerance. Gastroenterology 134, 727-737.
33. Paratcha, G., and Ledda, F. (2008). GDNF and GFRα: A versatile molecular complex for developing neurons. Trends Neurosci. 31, 384-391.
34. Pittenger, G., and Vinik, A. (2003). Nerve growth factor and diabetic neuropathy. Exp. Diabesity Res. 4, 271-285.
35. Pradat, P.F., Kennel, P., Naimi-Sadaoui, S., Finiels, F., Orsini, C., Revah, F., Delaere, P., and Mallet, J. (2001). Continuous delivery of neurotrophin 3 by gene therapy has a neuroprotective effect in experimental models of diabetic and acrylamide neuropathies. Hum. Gene Ther. 12, 2237-2249.
36. Ramer, M.S., Bradbury, E.J., Michael, G.J., Lever, I.J., and McMahon, S.B. (2003). Glial cell line-derived neurotrophic factor increases calcitonin gene-related peptide immunoreactivity in sensory and motoneurons in vivo. Eur. J. Neurosci. 18, 2713-2721.
37. Sagot, Y., Tan, S.A., Hammang, J.P., Aebischer, P., and Kato, A.C. (1996). GDNF slows loss of motoneurons but not axonal degeneration or premature death of pmn/pmn mice. J. Neurosci. 16, 2335-2341.
38. Said, G. (2007). Focal and multifocal diabetic neuropathies. Arq. Neuropsiquiatr. 65, 1272-1278.
39. Sariola, H., and Saarma, M. (2003). Novel functions and signalling pathways for GDNF. J. Cell Sci. 116, 3855-3862.
40. 125I]nerve growth factor in ileal mesenteric nerves in vitro: Effect of streptozotocin diabetes. Brain Res. 378, 325-336.
41. Siemionow, M., and Demir, Y. (2004). Diabetic neuropathy: Pathogenesis and treatment. J. Reconstr.Microsurg. 20, 241-252.
42. Skoff, A.M., Resta, C., Swamydas, M., and Adler, J.E. (2003). Nerve growth factor (NGF) and glial cell line-derived neurotrophic factor (GDNF) regulate substance P release in adult spinal sensory neurons. Neurochem. Res. 28, 847-854.
43. Springer, J.E., Mu, X., Bergmann, L.W., and Trojanowski, J.Q. (1994). Expression of GDNF mRNA in rat and human nervous tissue. Exp. Neurol. 127, 167-170.
44. Su, C.Y., Huang, H.T., Liu, H.Y., Huang, C.C., and Chien, C.Y. (2006). Scanning electron microscopic study of the nasolabial cyst: Its clinical and embryological implications. Laryngoscope 116, 307-311.
45. Tai, M.H., Cheng, H., Wu, J.P., Liu, Y.L., Lin, P.R., Kuo, J.S., Tseng, C.J., and Tzeng, S.F. (2003). Gene transfer of glial cell line-derived neurotrophic factor promotes functional recovery following spinal cord contusion. Exp. Neurol. 183, 508-515.
46. Trupp, M., Ryden, M., Jornvall, H., Funakoshi, H., Timmusk, T., Arenas, E., and Ibanez, C.F. (1995). Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons. J. Cell Biol. 130, 137-148.
47. Trupp, M., Belluardo, N., Funakoshi, H., and Ibanez, C.F. (1997). Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-α indicates multiple mechanisms of trophic actions in the adult rat CNS. J. Neurosci. 17, 3554-3567.
48. Vinik, A.I. (1999). Diabetic neuropathy: Pathogenesis and therapy. Am. J. Med. 107, 17S-26S.
49. Vinik, A.I., Park, T.S., Stansberry, K.B., and Pittenger, G.L. (2000). Diabetic neuropathies. Diabetologia 43, 957-973.
50. Yamamoto, M., Sobue, G., Yamamoto, K., Terao, S., and Mitsuma, T. (1996). Expression of glial cell line-derived growth factor mRNA in the spinal cord and muscle in amyotrophic lateral sclerosis. Neurosci. Lett. 204, 117-120.